Immunology

MD IQ

Commentary

Atopic dermatitis: Five things to know

The incidence of AD has increased over the past several decades, and environmental factors such as climate change have been implicated as a...

News from the FDA/CDC

FDA approves first tocilizumab biosimilar

Tocilizumab-bavi (Tofidence) will offer a lower-cost option for patients with autoimmune conditions, the drug manufacturer, Biogen, stated.

Pages